ALEC - Alector, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $-0.39
|
Rev Est: $2.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$3.25
DETAILS
HIGH:
$5.00
LOW:
$1.50
MEDIAN:
$3.25
CONSENSUS:
$3.25
UPSIDE:
48.40%
Market Cap:
239.04M
Volume:
516,442
Avg Volume:
1,168,148
52 Week Range:
0.87-3.4
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.63
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
175
IPO Date:
2019-02-07
EPS (TTM):
-1.23
P/E Ratio:
-1.53
Revenue (TTM):
100.56M
Total Assets:
468.30M
Total Debt:
42.52M
Cash & Equiv:
33.02M
Rev Growth (5Y):
36.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-42.2%
Debt/Equity:
0.34
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.34 | $-0.42 | +19.0% | $3.3M | $1.8M | +82.8% |
| 2025-08-07 | $-0.30 | $-0.45 | +33.3% | $7.9M | $2.8M | +180.7% |
| 2025-05-08 | $-0.41 | $-0.44 | +6.8% | $3.7M | $4.2M | -13.6% |
| 2025-02-26 | $-0.02 | $-0.61 | +96.7% | $54.2M | $20.4M | +165.8% |
| 2024-11-06 | $-0.43 | $-0.53 | +18.9% | $15.3M | $16.3M | -5.8% |
| 2024-08-07 | $-0.40 | $-0.49 | +18.4% | $15.1M | $14.4M | +4.7% |
| 2024-05-08 | $-0.38 | $-0.48 | +20.8% | $15.9M | $14.8M | +7.4% |
| 2024-02-27 | $-0.49 | $-0.80 | +38.8% | $15.2M | $9.6M | +57.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 100.56M | 97.06M | 133.62M | 207.09M | 21.10M | 21.22M | 27.68M | 3.73M | 416,000 |
| Net Income | (119.05M) | (130.39M) | (133.31M) | (36.33M) | (190.23M) | (105.39M) | (52.25M) | (32.48M) | (15.11M) |
| EPS | -1.23 | -1.56 | -1.62 | -0.45 | -2.45 | -1.62 | -0.76 | -0.63 | -1.78 |
| Total Assets | 468.30M | 621.83M | 787.65M | 814.66M | 488.25M | 421.91M | 308.36M | 236.06M | 54.11M |
| Total Debt | 42.52M | 38.92M | 43.33M | 47.60M | 51.26M | 48.04M | 0 | 0 | 0 |
| Cash & Equivalents | 33.02M | 74.56M | 154.32M | 329.15M | 49.97M | 89.64M | 65.47M | 32.45M | 50.84M |
| Operating Cash Flow | (229.91M) | (184.16M) | (20.33M) | 298.55M | (166.73M) | (99.31M) | 127.46M | (17.77M) | (12.99M) |
| Free Cash Flow | (231.16M) | (186.54M) | (24.45M) | 295.30M | (171.77M) | (114.57M) | 125.58M | (18.57M) | (15.24M) |
| FCF per Share | -2.39 | -2.23 | -0.30 | 3.67 | -2.21 | -1.86 | 1.84 | -0.36 | -1.79 |
| Book Value | 126.80M | 134.16M | 214.44M | 300.72M | 267.53M | 194.74M | (97.40M) | (52.03M) | (24.91M) |
| Cash & ST Investments | 413.40M | 548.86M | 712.85M | 735.25M | 413.31M | 353.07M | 290.41M | 32.45M | 50.84M |
| ROC Equity | -0.94 | -0.97 | -0.62 | -0.12 | -0.71 | -0.54 | N/A | N/A | N/A |